Neu REFIX beta glucans improving Multiple Sclerosis patients’ gut microbiome awarded as the best poster in 6th Microbiome Asia Conference in Tokyo 26~27 April 2023

Beneficial gut microbiome increase and harmful ones getting controlled after 60 day consumption of Neu REFIX in a clinical study undertaken jointly with Multiple Sclerosis Society of India was chosen as the best presentation ( in the meeting jointly hosted with Japanese Society of Probiotic Science (JSPS).

The clinical study outcome has been selected for a presentation in the Consortium of Multiple Sclerosis Centers annual conference to be held in Colarado USA between 29 May ~ 02 June 2023.

Other News

Other articles